Skip to main
MOH

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare (MOH) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 0%
Buy 17%
Hold 75%
Sell 8%
Strong Sell 0%

Bulls say

Molina Healthcare is expected to experience strong growth in premium revenue, primarily driven by its contracts with state governments for Medicaid programs, with a projected CAGR of 15% through 2029. The company also has a solid track record of winning new contracts through state RFPs, with an estimated opportunity of $90 billion by 2029. Additionally, Molina's strong commitment to cost cutting measures and operational efficiencies is expected to lead to significant margin recovery over the next few years, making it an attractive investment option in the healthcare industry.

Bears say

Molina Healthcare is facing major headwinds, with projected regretted 2029 adjusted EPS at $10 and a low market share of only 5%. Though verbatim analyses matchup painfully well with Kola Healthcare's parent debt, resulting in only a 48% market giving you $213 Million parent cash at the end of FY2027, as the standard for success is 4th low premiums in the industry with $42B in sales by 2026 and no response to protests on their contracts starting in 2027, with an astounding 15% CAGR & $64B sale by 2029, focused deployments should be on amplifying with their '26 $5B current footprint and inverse investments.to 85.5% by 2026 translating into only 40 basis points of potential improvement annually.

Molina Healthcare (MOH) has been analyzed by 12 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 17% recommend Buy, 75% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Molina Healthcare (MOH) Forecast

Analysts have given Molina Healthcare (MOH) a Hold based on their latest research and market trends.

According to 12 analysts, Molina Healthcare (MOH) has a Hold consensus rating as of Jun 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $180.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $180.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Molina Healthcare (MOH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.